These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11966737)

  • 1. Effects of GH on lipid peroxidation and neutrophil superoxide anion-generating capacity in hypopituitary adults with GH deficiency.
    Smith JC; Lang D; McEneny J; Evans LM; Scanlon MF; Young I; Davies J
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):449-55. PubMed ID: 11966737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.
    Smith JC; Evans LM; Wilkinson I; Goodfellow J; Cockcroft JR; Scanlon MF; Davies JS
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):493-501. PubMed ID: 11966742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners.
    Davies JS; Obuobie K; Smith J; Rees DA; Furlong A; Davies N; Evans LM; Scanlon MF
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):295-303. PubMed ID: 10718827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
    Evans LM; Davies JS; Goodfellow J; Rees JA; Scanlon MF
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):457-64. PubMed ID: 10468904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
    Rizzo M; Trepp R; Berneis K; Christ ER
    Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
    Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency.
    Evans LM; Davies JS; Anderson RA; Ellis GR; Jackson SK; Lewis MJ; Frenneaux MP; Rees A; Scanlon MF
    Eur J Endocrinol; 2000 Mar; 142(3):254-62. PubMed ID: 10700719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
    al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study.
    Christ ER; Cummings MH; Lumb PJ; Crook MA; Sönksen PH; Russell-Jones DL
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):173-9. PubMed ID: 10468987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.
    Li Voon Chong JS; Benbow S; Foy P; Wallymahmed ME; Wile D; MacFarlane IA
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):551-9. PubMed ID: 11106915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The favourable effects of growth hormone (GH) substitution on hypercholesterolaemia in GH-deficient adults are not associated with concomitant reductions in adiposity. A 12 month placebo-controlled study.
    Vahl N; Jørgensen JO; Hansen TB; Klausen IB; Jurik AG; Hagen C; Christiansen JS
    Int J Obes Relat Metab Disord; 1998 Jun; 22(6):529-36. PubMed ID: 9665673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
    O'Neal DN; Hew FL; Best JD; Alford F
    Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate doses of hGH (0.64 mg/d) improve lipids but not cardiovascular function in GH-deficient adults with normal baseline cardiac function.
    Newman CB; Frisch KA; Rosenzweig B; Roubenoff R; Rey M; Kidder T; Kong Y; Pursnani A; Sedlis SP; Schwartzbard A; Kleinberg DL
    J Clin Endocrinol Metab; 2011 Jan; 96(1):122-32. PubMed ID: 20926529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls.
    Li Voon Chong JS; Groves T; Foy P; Wallymahmed ME; MacFarlane IA
    Clin Endocrinol (Oxf); 2002 Feb; 56(2):175-81. PubMed ID: 11874408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
    Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.
    al-Shoumer KA; Gray R; Anyaoku V; Hughes C; Beshyah S; Richmond W; Johnston DG
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):795-802. PubMed ID: 9713570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.